Understanding Chronic Treatments by Patients Over 65 Years of Age

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07241299

Acronym

ordonnance

Enrollment

150

Registered

2025-11-21

Start date

2025-11-17

Completion date

2026-09-05

Last updated

2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Treatments

Keywords

chronic treatments, patients over 65 years

Brief summary

The ageing of the French population is accompanied by an increase in the number of chronic conditions per person. In 2008, according to IRDES (Institute for Research and Documentation in Health Economics), the average number of reported illnesses was six for people over the age of 65. This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance. One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.

Detailed description

Objectives Primary: To describe the understanding of chronic treatments by patients over 65 years of age. Secondary: To investigate the factors associated with the understanding of chronic treatments by patients over 65 years of age.

Interventions

OTHERdata collection

Data collection

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* Are aged 65 or over * Consulting one of the general practitioners agreeing to participate in the study * Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months) * Agree to participate in the study.

Exclusion criteria

* Does not understand French, * Has neurocognitive disorders * Lives in a medical facility * Consulting for an acute condition and whose prescription does not include chronic treatment. * Protected by law (guardianship, curatorship, judicial protection),

Design outcomes

Primary

Measure	Time frame	Description
Understanding each chronic treatment listed on the prescription	Day 0	A complete understanding of each chronic treatment, defined by knowledge of the dosage (number of doses and timing) and the indication for chronic treatment

Countries

France

Contacts

Primary ContactGestonnairedu CURRS

currs@univ-reims.fr0326918822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026